The statements below are read from DR LALCHANDANI LABS LIMITED’s filed results, 3 filed quarters and 9 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jun 4, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|
| Sales | 2.33 | 2.05 | 2.13 | -8.3% |
| 1.94 | 1.79 | 2.32 | +19.7% | |
| Operating profit | 0.39 | 0.26 | -0.19 | -147.7% |
| OPM % | 16.7% | 12.5% | -8.7% | -25.4 pp |
| Other income | 0.00 | 0.29 | -0.00 | -129.7% |
| Interest | 0.03 | 0.01 | 0.01 | -71.5% |
| Depreciation | 0.28 | 0.28 | 0.29 | +1.7% |
| Profit before tax | 0.20 | 0.26 | -0.16 | -181.8% |
| Tax % | -33.2% | 25.2% | n/a (loss) | — |
| Net profit | 0.27 | 0.20 | -0.13 | -149.6% |
| EPS (₹) | 0.61 | 0.45 | -0.15 | -124.6% |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
